Skip to main content
. 2021 Jul 29;21(3):273–283. doi: 10.1007/s40268-021-00357-0

Fig. 2.

Fig. 2

Interaction of the novel 13-amino acid peptide inhibitor (13AApi) with the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) spike receptor-binding domain (RBD) restricts its interaction with host cell receptor angiotensin-converting enzyme 2 (ACE2) peptidase domain. Molecular docking complex of the 13AApi (red) with SARS-CoV-2 spike RBD (green) obtained with pyDockWEB. The interacting residues within the 3 Å region are highlighted in cyan and blue, respectively, while the dock scores (kcal/mol) from all three docking suits (pyDockWEB, HDOCK, and ClusPro 2.0) are listed in the table below